Prescription drug · NDA
Xiidra (Lifitegrast) NDC 24208-911
Lifitegrast 50 mg/mL · Solution/ drops · Ophthalmic · Bausch & Lomb Incorporated
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 24208-911-12 | 24208091112 | 12 POUCH in 1 CARTON (24208-911-12) / 5 AMPULE in 1 POUCH (24208-911-05) / .2 mL in 1 AMPULEMarketed from Jan 2, 2024 | |
| 24208-911-94 | 24208091194 | 4 POUCH in 1 CARTON (24208-911-94) / 5 AMPULE in 1 POUCH (24208-911-95) / .2 mL in 1 AMPULEMarketed from Jan 2, 2024 · Sample package |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Xiidra
- Generic name (nonproprietary)
- lifitegrast
- Active ingredients
- Lifitegrast — 50 mg/mL
- Dosage form
- Solution/ drops
- Route
- Ophthalmic
- Labeler
- Bausch & Lomb IncorporatedNDC labeler code 24208
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 208073
- Marketing start
- Listing expires
- Other FDA classes
- Lymphocyte Function-Associated Antigen-1 Antagonists (Mechanism)
- Identifiers
- Product ID 24208-911_2770cd53-f66c-2097-e063-6394a90a874bSPL ID 2770cd53-f66c-2097-e063-6394a90a874bSPL set ID 1a914080-a3c0-44be-b601-0ae3160e77ebRxCUI 1801835, 1801840UNII 038E5L962W
- Pharmacologic class
- Lymphocyte Function-Associated Antigen-1 Antagonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N424208091112followed by a unit qualifier and the quantityPackage 24208-0911-12. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Xiidra ® (lifitegrast ophthalmic solution) 5% is indicated for the treatment of the signs and symptoms of dry eye disease (DED). Xiidra (lifitegrast ophthalmic solution) 5% is a lymphocyte function-associated antigen-1 (LFA-1) antagonist indicated for the treatment of the signs and symptoms of dry eye disease (DED). ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 24208-911
- What is NDC 24208-911?
- 24208-911 is the product NDC for Xiidra (lifitegrast), Lifitegrast 50 mg/mL solution/ drops, listed with the FDA by Bausch & Lomb Incorporated. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Xiidra (Lifitegrast).
- What is the active ingredient?
- Lifitegrast.
- Who is the labeler?
- Bausch & Lomb Incorporated, NDC labeler code 24208. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Xiidra?
- 1 other product NDC are listed under this name. See all Xiidra NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Xiidra products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Xiidralifitegrast | Lifitegrast 50 mg/mL | Solution/ dropsOphthalmic | Novartis Pharmaceuticals Corporation | 0078-0911 | 00078-0911-1200078-0911-94 |
Other NDCs under NDA 208073
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Xiidralifitegrast | Lifitegrast 50 mg/mL | Solution/ dropsOphthalmic | Novartis Pharmaceuticals Corporation | 0078-0911 |